Value of a confirmatory re‐biopsy as part of a modern risk stratified cancer surveillance programme for early prostate cancer

Value of a confirmatory re‐biopsy as part of a modern risk stratified cancer surveillance programme for early prostate cancer

Saved in:

Bibliographic Details
Main Authors:	Harry Gabb, Vincent J. Gnanapragasam
Format:	Article
Language:	English
Published:	Wiley 2024-07-01
Series:	BJUI Compass
Subjects:	active surveillance Cambridge Prognostic Groups confirmatory biopsy prostate cancer risk‐based follow‐up stratified cancer surveillance
Online Access:	https://doi.org/10.1002/bco2.406
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Confirmatory Biopsy Outcomes in Patients with Grade Group 2 Prostate Cancer: Implications for Early Management
by: Riccardo Leni, et al.
Published: (2025-02-01)

Rendre visibles les conséquences de la surveillance numérique
by: Camila Pérez Lagos
Published: (2020-09-01)

Clinical utility of transperineal template-guided mapping prostate biopsy in a selection of patients under active surveillance and confirmation of patients with negative biopsy for prostate cancer
by: Michael Jakun Koo, et al.
Published: (2025-03-01)

The INFLUENCE 3.0 model: Updated predictions of locoregional recurrence and contralateral breast cancer, now also suitable for patients treated with neoadjuvant systemic therapy
by: M.C. Van Maaren, et al.
Published: (2025-02-01)

Relapse detection in the Danish surveillance program of patients with clinical stage I seminoma: a nationwide study
by: Niklas B. Lindahl, et al.
Published: (2025-01-01)

Clinical Evidence of Methods and Timing of Proper Follow-Up for Head and Neck Cancers
by: Riccardo Gili, et al.
Published: (2024-09-01)

Active surveillance vs. surgery in low‐risk papillary thyroid microcarcinoma patients and the risk of loss to follow‐up
by: Yoshiyuki Saito, et al.
Published: (2024-08-01)

Ten-year follow-up of atypical small acinar hyperplasia cases diagnosed by initial prostate biopsy
by: Rui Su, et al.
Published: (2025-05-01)

Long-term Surveillance Outcomes of Prostate Cancer Patients Eligible for Active Surveillance but Who Underwent Radical Prostatectomy
by: Şakir Ongün, et al.
Published: (2024-09-01)

The Clinical Applications of Tissue Biomarkers in Prostate Cancer
by: Peter Lonergan, Samuel Washington, Maxwell Meng, Renu Eapen
Published: (2020-10-01)

Evaluation of Dodoma cervical cancer population-based surveillance system at Dodoma Tanzania, January to December 2022
by: Godbless Henry Mfuru, et al.
Published: (2025-06-01)

Is Colonoscopic Surveillance Necessary after Curative Resection of Colorectal Cancer in Elderly Patients?
by: Suat Chin Ng, et al.
Published: (2019-07-01)

A Markov cohort model for Endoscopic surveillance and management of Barrett’s esophagus
by: Ravi Vissapragada, et al.
Published: (2024-12-01)

Active Surveillance in Early Thyroid Cancer: A Meta-Analysis
by: Li-Jen Liao, et al.
Published: (2024-11-01)

Clinician perceptions on barriers and facilitators to 1‐year surveillance colonoscopy completion in survivors of colorectal cancer
by: C. Natasha Kwendakwema, et al.
Published: (2024-09-01)

Reliability and validity of a national intelligent infectious disease surveillance and early warning maturity questionnaire
by: Qingliang LIU, et al.
Published: (2025-01-01)

Incorporating the NICE Cambridge Prognostic Groups and Predict Prostate into a structured informed‐decision making clinic reduces over‐treatment rates of early prostate cancer
by: Vincent J. Gnanapragasam, et al.
Published: (2025-06-01)

A scoping review of active, participant centred, digital adverse events following immunization (AEFI) surveillance of WHO approved COVID-19 vaccines: A Canadian immunization Research Network study
by: Mohamed Serhan, et al.
Published: (2024-12-01)

External Validation of the International Staging Collaboration for Cancer of the Prostate (STAR-CAP) Prognostic System in Patients Managed with Active Surveillance
by: Alejandro Berlin, et al.
Published: (2025-09-01)

Proceedings of the Canadian Thyroid Cancer Active Surveillance Study Group 2019 national investigator meeting
by: David P. Goldstein, et al.
Published: (2021-06-01)

Modern Approach in Radiological Diagnosis of Prostate Cancer (Systematic Review of International Clinical Guidelines and Clinical Studies Over 2014–2020)
by: A. V. Vasilyev, et al.
Published: (2021-01-01)

Surveillance for adverse events following immunization in Hebei Province, China, 2018-2020
by: Li Sun, et al.
Published: (2024-12-01)

Four magnetic resonance imaging surveillance-detected breast cancer cases in cancer-free BRCA1/2 mutation carriers
by: Megumi Takaoka, et al.
Published: (2021-10-01)

Time of developing surgical site infections and its association with patient and procedure characteristics
by: Saad A. Almohrij
Published: (2025-05-01)

Model of care for individuals with rare cancer predisposition syndromes in Germany
by: Valentina Härter, et al.
Published: (2025-09-01)

Active surveillance for prostate cancer: to whom, when and how
by: M. S. Taratkin, et al.
Published: (2019-09-01)

Surveillance for melanoma and other skin cancers at the regional level
by: A. I. Blokh, et al.
Published: (2020-03-01)

Critical Surveillance Studies in the Information Society
by: Thomas Allmer
Published: (2011-11-01)

Evaluation of microRNAs as liquid biopsy markers in adrenocortical tumors
by: Chrysoula Mytareli, et al.
Published: (2025-01-01)

Internet surveillance, regulation, and chilling effects online: a comparative case study
by: Jonathon W. Penney
Published: (2017-05-01)

Colorectal cancer in Crohn’s disease: a series of 6 cases
by: Kazuhide Ishimaru, et al.
Published: (2021-06-01)

Parental Reports on Late Effects and Follow-Up Needs: A Single-Center Assessment of Childhood Cancer Survivorship Care in Kenya
by: Susan Nyabate Mageto, et al.
Published: (2025-03-01)

Evaluating Management of Extra-Abdominal Desmoid Fibromatosis: A Retrospective Analysis of Treatments, Outcomes and Recurrence Patterns
by: Vidhi Saraf, et al.
Published: (2025-05-01)

Rates of primary and secondary treatments for patients on active surveillance for localized prostate cancer—A population‐based cohort study
by: Rano Matta, et al.
Published: (2020-10-01)

Triggers for transition from active surveillance to radical treatment of prostate cancer 2008–2020 – a case-control study
by: Mats Ahlberg, et al.
Published: (2024-03-01)

A national survey of physicians regarding active surveillance for low-risk thyroid cancer in Korea
by: Min Joo Kim, et al.
Published: (2025-01-01)

A systematic review and comparative evaluation to develop and validate a comprehensive framework for cancer surveillance systems
by: Mohsen Soleimani, et al.
Published: (2025-04-01)

Immune surveillance as a pharmacological target in the early stages of cancer
by: Hongfei Jiang, et al.
Published: (2025-07-01)

Durability of Active Surveillance for Localized Renal Masses: 3-year Outcomes in the Michigan Urological Surgery Improvement Collaborative
by: Yuzhi Wang, et al.
Published: (2025-05-01)

Time trends for the use of active surveillance and deferred treatment for localised prostate cancer in Sweden: a nationwide study
by: Jovana Maljkovic, et al.
Published: (2024-12-01)